1.

Record Nr.

UNINA9910449899103321

Autore

Collins Judith M

Titolo

Preventing identity theft in your business [[electronic resource] ] : how to protect your business, customers, and employees / / Judith M. Collins

Pubbl/distr/stampa

Hoboken, N.J., : Wiley, c2005

ISBN

1-280-25503-X

9786610255030

0-471-72132-8

Edizione

[1st edition]

Descrizione fisica

1 online resource (257 p.)

Disciplina

658.4/72

Soggetti

Identity theft - United States - Prevention

Electronic books.

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

What is an "identity"? -- Identity theft: effects on victims -- Identity crime is entrenched -- Identity crimes are escalating -- Legal requirements for business -- Caveat lector. let the reader beware -- Your business identities -- Tighten your business borders -- Securing the people front: the security job analysis -- The people front: recruitment for security -- The people front: personnel selection for security -- The people front: select for motivation -- The people front: select for integrity and security -- The people front: select for interpersonal skills -- Socialization, company culture, and the realistic job preview -- The security orientation program: socializing newcomers to the honest company culture -- The people front: appraisal and feedback for performance and security -- The process front: secure business information processes -- The property front: the e-business web site -- The customer security program -- E-commerce "best practices" for customers -- The legislative process -- HIPAA: security for health care companies.

Sommario/riassunto

Preventing Identity Theft in Your Business is a reliable guide to help protect companies, their customers, and their employees from the growing problem of identity theft. Real-life examples show managers



and executives how to identify business, customer, and employee identity theft, how these crimes are committed, how best to prevent them, and overall, develop an honest company culture. It also covers how to manage this threat in business reorganizations such as mergers, acquisitions, globalization, and outsourcing.Judith M. Collins (East Lansing, MI) is Associate Professor of Industrial a

2.

Record Nr.

UNINA9910137088203321

Autore

Petranel Theresa Ferrao

Titolo

Cellular and phenotypic plasticity in cancer [[electronic resource] /] / edited by Petranel Theresa Ferrao, Andreas Behren, Robin Andersonand Erik Thompson

Pubbl/distr/stampa

Frontiers Media SA, 2015

France : , : Frontiers Media SA, , 2015

ISBN

9782889196623 (ebook)

Descrizione fisica

1 online resource (77 pages) : illustrations

Collana

Frontiers Research Topics

Soggetti

Cancer

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Nota di bibliografia

Includes bibliographical references.

Sommario/riassunto

The process of Epithelial-Mesenchymal-Transition (EMT) is known to result in a phenotype change in cells from a proliferative state to a more invasive state. EMT has been reported to drive the metastatic spread of various cancers and has also been associated with drug resistance to cytotoxics and targeted therapeutics. Recently phenotype switching akin to EMT has been reported in non-epithelial cancers such as metastatic melanoma. This process involves changes in EMT-Transcription Factors (EMT-TFs), suggesting that phenotype-switching may be common to several tumour types. It remains unclear as to whether the presence of both Epilthelial-like and Mesenchymal-like cells are a pre-requisite for phenotype switching within a tumour, how this heterogeneity is regulated, and if alteration of cell phenotype is sufficient to mediate migratory changes, or whether drivers of cell



migration result in an associated phenotype switch in cancer cells. Similarly it has yet to be clarified if cells in an altered phenotype can be refractory to drug therapy or whether mediators of drug resistance induce a concurrent phenotypic change. Little is known today about the underlying genetic, epigenetic and transient changes that accompany this phenotypic switch and about the role for the tumor micro-environment in influencing it. Hence this is currently an area of speculation and keen interest in the Oncology field with wide-ranging translational implications. In this Frontiers Research Topic, we discuss our current understanding of these concepts in various cancer types including breast cancer, colorectal cancer and metastatic melanoma. This topic covers how these processes of cellular and phenotypic plasticity are regulated and how they relate to cancer initiation, progression, dormancy, metastases and response to cytotoxics or targeted therapies.